ASX - By Stock
|
PAR |
Re:
Chart
|
|
Nike77
|
4.3K |
3.8M |
11 |
02/07/24 |
02/07/24 |
ASX - By Stock
|
4.3K
|
3.8M
|
11
|
|
ASX - By Stock
|
PAR |
Re:
Where we at?
|
|
Nike77
|
706 |
258K |
6 |
02/05/24 |
02/05/24 |
ASX - By Stock
|
706
|
258K
|
6
|
|
ASX - By Stock
|
PAR |
Re:
Where we at?
|
|
Nike77
|
706 |
258K |
6 |
18/04/24 |
18/04/24 |
ASX - By Stock
|
706
|
258K
|
6
|
|
ASX - By Stock
|
PAR |
Re:
Where we at?
|
|
Nike77
|
706 |
258K |
6 |
10/04/24 |
10/04/24 |
ASX - By Stock
|
706
|
258K
|
6
|
|
ASX - By Stock
|
PAR |
Re:
Ann: PAR Appoints Business Development Consultant
|
|
Nike77
|
327 |
110K |
4 |
21/02/24 |
21/02/24 |
ASX - By Stock
|
327
|
110K
|
4
|
|
ASX - By Stock
|
PAR |
Re:
Ann: PAR Appoints Business Development Consultant
|
|
Nike77
|
327 |
110K |
4 |
15/02/24 |
15/02/24 |
ASX - By Stock
|
327
|
110K
|
4
|
|
ASX - By Stock
|
PAR |
Re:
Ann: PAR Appoints Business Development Consultant
|
|
Nike77
|
327 |
110K |
2 |
09/02/24 |
09/02/24 |
ASX - By Stock
|
327
|
110K
|
2
|
|
ASX - By Stock
|
PAR |
Re:
PAR. SP
|
|
Nike77
|
1.2K |
430K |
2 |
29/01/24 |
29/01/24 |
ASX - By Stock
|
1.2K
|
430K
|
2
|
|
ASX - By Stock
|
PAR |
Re:
PAR. SP
|
|
Nike77
|
1.2K |
430K |
3 |
16/01/24 |
16/01/24 |
ASX - By Stock
|
1.2K
|
430K
|
3
|
|
ASX - By Stock
|
PAR |
Re:
PAR. SP
|
|
Nike77
|
1.2K |
430K |
6 |
16/01/24 |
16/01/24 |
ASX - By Stock
|
1.2K
|
430K
|
6
|
|
ASX - By Stock
|
PAR |
Re:
PAR. SP
|
|
Nike77
|
1.2K |
430K |
17 |
07/12/23 |
07/12/23 |
ASX - By Stock
|
1.2K
|
430K
|
17
|
|
ASX - By Stock
|
PAR |
Re:
Ann: PAR Successful Placement and Fully Underwritten ANREO
|
|
Nike77
|
191 |
58K |
11 |
01/11/23 |
01/11/23 |
ASX - By Stock
|
191
|
58K
|
11
|
|
ASX - By Stock
|
PAR |
Re:
Ann: iPPS Increases Cartilage Thickness in Phase 2 Trial
|
|
Nike77
|
218 |
76K |
2 |
30/10/23 |
30/10/23 |
ASX - By Stock
|
218
|
76K
|
2
|
|
ASX - By Stock
|
PAR |
Re:
Ann: iPPS Increases Cartilage Thickness in Phase 2 Trial
|
|
Nike77
|
218 |
76K |
21 |
18/10/23 |
18/10/23 |
ASX - By Stock
|
218
|
76K
|
21
|
|
ASX - By Stock
|
PAR |
Re:
What do YOU choose?
|
|
Nike77
|
51 |
18K |
2 |
07/06/23 |
07/06/23 |
ASX - By Stock
|
51
|
18K
|
2
|
|
ASX - By Stock
|
PAR |
Re:
Ann: Change of Director's Interest Notice - Fisher
|
|
Nike77
|
12 |
5.7K |
6 |
22/05/23 |
22/05/23 |
ASX - By Stock
|
12
|
5.7K
|
6
|
|
ASX - By Stock
|
PAR |
Re:
The screen behind the scene...
|
|
Nike77
|
41 |
13K |
9 |
22/05/23 |
22/05/23 |
ASX - By Stock
|
41
|
13K
|
9
|
|
ASX - By Stock
|
PAR |
Re:
The screen behind the scene...
|
|
Nike77
|
41 |
13K |
5 |
22/05/23 |
22/05/23 |
ASX - By Stock
|
41
|
13K
|
5
|
|
ASX - By Stock
|
PAR |
Re:
The screen behind the scene...
|
|
Nike77
|
41 |
13K |
3 |
22/05/23 |
22/05/23 |
ASX - By Stock
|
41
|
13K
|
3
|
|
ASX - By Stock
|
PAR |
Re:
The screen behind the scene...
|
|
Nike77
|
41 |
13K |
6 |
17/05/23 |
17/05/23 |
ASX - By Stock
|
41
|
13K
|
6
|
|
ASX - By Stock
|
PAR |
Re:
Chart
|
|
Nike77
|
4.3K |
3.8M |
6 |
10/05/23 |
10/05/23 |
ASX - By Stock
|
4.3K
|
3.8M
|
6
|
|
ASX - By Stock
|
PAR |
Re:
Funding options
|
|
Nike77
|
20 |
6.9K |
4 |
03/05/23 |
03/05/23 |
ASX - By Stock
|
20
|
6.9K
|
4
|
|
ASX - By Stock
|
PAR |
Re:
PAR and the BML findings
|
|
Nike77
|
31 |
10K |
5 |
24/04/23 |
24/04/23 |
ASX - By Stock
|
31
|
10K
|
5
|
|
ASX - By Stock
|
PAR |
Re:
Ann: iPPS Demonstrates Multiple DMOAD Signals in Phase 2 Study
|
|
Nike77
|
386 |
168K |
25 |
18/04/23 |
18/04/23 |
ASX - By Stock
|
386
|
168K
|
25
|
|
ASX - By Stock
|
PAR |
Re:
Ann: iPPS Demonstrates Multiple DMOAD Signals in Phase 2 Study
|
|
Nike77
|
386 |
168K |
5 |
13/04/23 |
13/04/23 |
ASX - By Stock
|
386
|
168K
|
5
|
|
ASX - By Stock
|
PAR |
Re:
Ann: Change of Chief Financial Officer
|
|
Nike77
|
45 |
17K |
7 |
03/03/23 |
03/03/23 |
ASX - By Stock
|
45
|
17K
|
7
|
|
ASX - By Stock
|
PAR |
Beech forests and climate change
|
|
Nike77
|
1 |
791 |
2 |
19/10/22 |
19/10/22 |
ASX - By Stock
|
1
|
791
|
2
|
|
ASX - By Stock
|
PAR |
Re:
Ann: PAR Reports Successful Primary Endpoint in Phase 2 Trial
|
|
Nike77
|
115 |
65K |
2 |
04/10/22 |
04/10/22 |
ASX - By Stock
|
115
|
65K
|
2
|
|
ASX - By Stock
|
PAR |
Re:
Ann: Successful MPSVI Safety Review and PARA OA 008 Update
|
|
Nike77
|
104 |
41K |
8 |
26/09/22 |
26/09/22 |
ASX - By Stock
|
104
|
41K
|
8
|
|
ASX - By Stock
|
PAR |
Re:
Ann: Investor Presentation - $66m Capital Raise
|
|
Nike77
|
87 |
36K |
2 |
30/08/22 |
30/08/22 |
ASX - By Stock
|
87
|
36K
|
2
|
|
ASX - By Stock
|
PAR |
Lauren Jackson Australian basketballer and knee issues
|
|
Nike77
|
10 |
4.1K |
3 |
02/02/22 |
02/02/22 |
ASX - By Stock
|
10
|
4.1K
|
3
|
|
ASX - By Stock
|
PAR |
Long Covid and elevated inflammation levels
|
|
Nike77
|
2 |
1.2K |
6 |
14/01/22 |
14/01/22 |
ASX - By Stock
|
2
|
1.2K
|
6
|
|
ASX - By Stock
|
PAR |
Re:
Motor neuron disease (MND) and inflammation
|
|
Nike77
|
4 |
2.0K |
3 |
29/11/21 |
29/11/21 |
ASX - By Stock
|
4
|
2.0K
|
3
|
|
ASX - By Stock
|
PAR |
Re:
Motor neuron disease (MND) and inflammation
|
|
Nike77
|
4 |
2.0K |
1 |
29/11/21 |
29/11/21 |
ASX - By Stock
|
4
|
2.0K
|
1
|
|
ASX - By Stock
|
PAR |
Motor neuron disease (MND) and inflammation
|
|
Nike77
|
4 |
2.0K |
7 |
29/11/21 |
29/11/21 |
ASX - By Stock
|
4
|
2.0K
|
7
|
|
ASX - By Stock
|
PAR |
Re:
research reports and media
|
|
Nike77
|
4.4K |
2.0M |
0 |
10/11/21 |
10/11/21 |
ASX - By Stock
|
4.4K
|
2.0M
|
0
|
|
ASX - By Stock
|
PAR |
Re:
Ann: Paradigm Presentation to Bell Potter Healthcare Conference
|
|
Nike77
|
54 |
21K |
17 |
09/11/21 |
09/11/21 |
ASX - By Stock
|
54
|
21K
|
17
|
|
ASX - By Stock
|
PAR |
Re:
Ann: Trading Halt
|
|
Nike77
|
150 |
75K |
10 |
01/11/21 |
01/11/21 |
ASX - By Stock
|
150
|
75K
|
10
|
|
ASX - By Stock
|
PAR |
Re:
Chart
|
|
Nike77
|
4.3K |
3.8M |
27 |
25/10/21 |
25/10/21 |
ASX - By Stock
|
4.3K
|
3.8M
|
27
|
|
ASX - By Stock
|
PAR |
Re:
research reports and media
|
|
Nike77
|
4.4K |
2.0M |
8 |
18/10/21 |
18/10/21 |
ASX - By Stock
|
4.4K
|
2.0M
|
8
|
|
ASX - By Stock
|
PAR |
Re:
CHIKUNGUNYA - PEER REVIEWED !!!
|
|
Nike77
|
38 |
14K |
1 |
09/09/21 |
09/09/21 |
ASX - By Stock
|
38
|
14K
|
1
|
|
ASX - By Stock
|
PAR |
Re:
Ann: PARADIGM REPORTS IND APPLICATION UPDATE
|
|
Nike77
|
150 |
61K |
0 |
03/08/21 |
03/08/21 |
ASX - By Stock
|
150
|
61K
|
0
|
|
ASX - By Stock
|
PAR |
Re:
Ann: Trading Halt
|
|
Nike77
|
318 |
138K |
16 |
30/07/21 |
30/07/21 |
ASX - By Stock
|
318
|
138K
|
16
|
|
ASX - By Stock
|
PAR |
Re:
research reports and media
|
|
Nike77
|
4.4K |
2.0M |
2 |
30/04/21 |
30/04/21 |
ASX - By Stock
|
4.4K
|
2.0M
|
2
|
|
ASX - By Stock
|
PAR |
Re:
research reports and media
|
|
Nike77
|
4.4K |
2.0M |
23 |
29/04/21 |
29/04/21 |
ASX - By Stock
|
4.4K
|
2.0M
|
23
|
|